Our Website Uses Cookies 


We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.


For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Navigating Challenges in Global Market Access for Life Science Companies

Date: Tuesday, November 10, 2020 1:00 PM - 2:00 PM

Join Covington experts Grant Castle, Rujul Desai, and Kristie Gurley as they discuss the potential impact of continued efforts by policy makers to bring U.S. market access and pricing regimes for innovative therapies closer to those used in European markets. Topics covered during this webinar will include:

  • U.S. policy proposals for international referencing pricing and use of health technology assessments (HTAs)
  • Overview of market access regimes used in the U.K. and Germany
  • Case studies from Europe on successfully challenging HTA reviews
  • Varying standards for HTAs such as NICE and ICER
  • Reviewing guidance on parallel trade in the European Union
  • Use of RWE and health economic outcomes data in addressing value across key stakeholders and markets
  • Evolving best practices for managing legal guidance, contracting, and compliance across global market access

Presenters:

Grant Castle
Partner
gcastle@cov.com
+44 20 7067 2006

Rujul Desai
Of Counsel
rdesai@cov.com
+1 202 662 5427

Kristie Gurley
Associate
kgurley@cov.com
+1 202 662 5454

Tuesday, November 10, 2020
1 - 2 p.m. ET

Log-in details will be provided upon registration.

For additional information or to register, please reach out to events@cov.com.